Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp IGXT


Primary Symbol: T.IGX

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Announces Management Changes

GlobeNewswire May 13, 2015

IntelGenx Announces Management Changes

Newsfile May 13, 2015

IntelGenx Confirms Execution of Lease and Construction Agreements

Newsfile May 5, 2015

IntelGenx to Report 2015 First Quarter Update Call on May 15, 2015

GlobeNewswire May 4, 2015

IntelGenx to Report 2015 First Quarter Update Call on May 15, 2015

Newsfile May 4, 2015

IntelGenx Provides Q1, 2015 Update on Sales of Forfivo XL(R)

Newsfile April 22, 2015

IntelGenx Announces Analyst Coverage Initiated by Singular Research

GlobeNewswire April 16, 2015

IntelGenx Announces Analyst Coverage Initiated by Singular Research

Newsfile April 16, 2015

IntelGenx Founder, President and CEO Dr. Horst Zerbe Interviewed on Fox Business Network's "After the Bell"

Newsfile April 10, 2015

IntelGenx Grants Stock Options

GlobeNewswire April 2, 2015

IntelGenx Grants Stock Options

Newsfile April 2, 2015

IntelGenx Reports 2014 Annual Results and Provides Corporate Development Update

Newsfile March 31, 2015

IntelGenx to Report 2014 Annual Results and Provide Corporate Development Update on March 31, 2015

GlobeNewswire March 23, 2015

IntelGenx to Report 2014 Annual Results and Provide Corporate Development Update on March 31, 2015

Newsfile March 23, 2015

IntelGenx Provides Update on Sales of Forfivo XL(R)

GlobeNewswire February 23, 2015

IntelGenx to Present at the 8th Annual OneMedForum

Newsfile January 5, 2015

IntelGenx to Present at the 8th Annual OneMedForum

GlobeNewswire January 5, 2015

IntelGenx Grants Stock Options

GlobeNewswire December 8, 2014

IntelGenx Grants Stock Options

Newsfile December 8, 2014

IntelGenx Grants Extension of Marketing Exclusivity in the U.S. to Edgemont of Forfivo XL(R)

GlobeNewswire December 2, 2014